Enzo Biochem Stock Filter Stocks by Fundamentals
ENZ Stock | USD 1.08 0.05 4.85% |
Enzo Biochem fundamentals help investors to digest information that contributes to Enzo Biochem's financial success or failures. It also enables traders to predict the movement of Enzo Stock. The fundamental analysis module provides a way to measure Enzo Biochem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Enzo Biochem stock.
Enzo | Shares Owned by Institutions |
Enzo Biochem Institutional Holders
Institutional Holdings refers to the ownership stake in Enzo Biochem that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Enzo Biochem's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Enzo Biochem's value.Shares | Bbr Partners, Llc | 2024-09-30 | 100 K | Nierenberg Investment Management Co | 2024-09-30 | 88.6 K | Northern Trust Corp | 2024-09-30 | 67.2 K | Lazard Asset Management Llc | 2024-06-30 | 50.5 K | T. Rowe Price Associates, Inc. | 2024-06-30 | 44.8 K | Xtx Topco Ltd | 2024-09-30 | 34.4 K | Citadel Advisors Llc | 2024-09-30 | 26.6 K | Kempner Capital Management Inc | 2024-09-30 | 25.5 K | Millennium Management Llc | 2024-06-30 | 19.4 K | Harbert Fund Advisors Inc | 2024-09-30 | 5.2 M | Renaissance Technologies Corp | 2024-09-30 | 2.5 M |
Enzo Fundamentals
Return On Equity | -0.15 | ||||
Return On Asset | -0.0744 | ||||
Profit Margin | (0.82) % | ||||
Operating Margin | (0.39) % | ||||
Current Valuation | 4.95 M | ||||
Shares Outstanding | 52.24 M | ||||
Shares Owned By Insiders | 21.57 % | ||||
Shares Owned By Institutions | 31.78 % | ||||
Number Of Shares Shorted | 432.99 K | ||||
Price To Earning | 26.60 X | ||||
Price To Book | 0.96 X | ||||
Price To Sales | 1.77 X | ||||
Revenue | 31.91 M | ||||
Gross Profit | 11.57 M | ||||
EBITDA | (8.35 M) | ||||
Net Income | (26.08 M) | ||||
Cash And Equivalents | 82.37 M | ||||
Cash Per Share | 0.44 X | ||||
Total Debt | 3.51 M | ||||
Debt To Equity | 0.38 % | ||||
Current Ratio | 2.21 X | ||||
Book Value Per Share | 1.07 X | ||||
Cash Flow From Operations | (26.26 M) | ||||
Short Ratio | 3.94 X | ||||
Earnings Per Share | (0.19) X | ||||
Target Price | 5.5 | ||||
Number Of Employees | 125 | ||||
Beta | 0.73 | ||||
Market Capitalization | 56.42 M | ||||
Total Asset | 85.76 M | ||||
Retained Earnings | (294.43 M) | ||||
Working Capital | 45.24 M | ||||
Current Asset | 91.4 M | ||||
Current Liabilities | 20.57 M | ||||
Annual Yield | 0.39 % | ||||
Net Asset | 85.76 M |
About Enzo Biochem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Enzo Biochem's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Enzo Biochem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Enzo Biochem based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Enzo Stock Analysis
When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.